Evidence map›Paper›PMID 33204387›Full record

ArticleThe World Allergy Organization journal2020

The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study.

Marcus Maurer, Karsten Weller, Markus Magerl, Rasmus Robin Maurer, Emanuel Vanegas, Miguel Felix, Annia Cherrez, Valeria L Mata, Alicja Kasperska-Zajac, Agnieszka Sikora and 27 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in The World Allergy Organization journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04893928 (Role of Information and Communication Technologies for Health Support in Inflammatory Bowel Diseases), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04893928 unknown statusnot on this mapstarted 2021, after this paper: background citation

Role of Information and Communication Technologies for Health Support in Inflammatory Bowel Diseases: The DAMASCO Trial (Stage I)

TypeobservationalSponsorHospital Nacional Profesor Alejandro PosadasRan2021 to 2022Enrolled351ConditionsInflammatory Bowel Diseases, Knowledge, Attitudes, Practice, Quality of Life, Treatment Adherence and ComplianceArmsQUECOMIICAT survey, Self-Efficacy for Appropriate Medication Use Scale, ICTs preferences and barriers survey, Focus group and IBD mobile App for health support (MAHS) development and validation
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. A Patient Charter for Chronic Urticaria.Advances in therapy · 2024
    Article
  7. CRUSEClinical and translational allergy · 2024
    Article
  8. Reinventing the wheal: A review of online misinformation and conspiracy theories in urticaria.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2023
    Review
  9. Urticaria.Nature reviews. Disease primers · 2022
    Review
  10. Article
  11. Social Media as a Medium for Dermatologic Education.Current dermatology reports · 2022
    Review
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 20 institutions in 17 countries.

Marcus MaurerDermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany.
Karsten WellerDermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany.
Markus MagerlDermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany.
Rasmus Robin MaurerDermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany.
Emanuel VanegasUniversidad Espíritu Santo, Samborondón, Ecuador.
Miguel FelixUniversidad Espíritu Santo, Samborondón, Ecuador.
Annia CherrezRespiralab, Respiralab Research Group, Guayaquil, Ecuador.
Valeria L MataUniversidad Espíritu Santo, Samborondón, Ecuador.
Alicja Kasperska-ZajacEuropean Center for Diagnosis and Treatment of Urticaria, Medical University of Silesia, Katowice, Poland.
Agnieszka SikoraEuropean Center for Diagnosis and Treatment of Urticaria, Medical University of Silesia, Katowice, Poland.
Daria FominaCity Center of Allergy and Immunology, Clinical City Hospital #52, Moscow, Russia.
Elena KovalkovaCity Center of Allergy and Immunology, Clinical City Hospital #52, Moscow, Russia.
Kiran GodseDepartment of Dermatology, D Y, Patil University School of Medicine and Hospital, Mumbai, India.
Nimmagadda Dheeraj RaoDepartment of Dermatology, D Y, Patil University School of Medicine and Hospital, Mumbai, India.
Maryam KhoshkhuiAllergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Sahar RastgooDepartment of Allergy and Immunology, Mashhad University of Medical Sciences, Mashhad, Iran.
Roberta Fachini Jardim CriadoDepartment of Dermatology, Faculdade de Medicina do ABC, São Paulo, Brazil.
Mohamed AbuzakoukAllergy and Immunology Department, Cleveland Clinic Abu Dhabi, The Uae.
Deepa GrandonAllergy and Immunology Department, Cleveland Clinic Abu Dhabi, The Uae.
Martijn van DoornDepartment of Dermatology, Erasmus MC, Rotterdam, the Netherlands.
Solange Olliveira Rodrigues ValleDepartment of Internal Medicine, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil.
Eduardo Magalhães de Souza LimaFaculty of Science and Health of Juiz de Fora - SUPREMA - Minas Gerais.
Simon Francis ThomsenDepartment of Dermatology, Bispebjerg Hospital, University of Copenhagen, Biomedical Sciences, Copenhagen, Denmark.
German D RamónInstituto de Alergia e Inmunología del Sur, Bahía Blanca, De Buenos Aires, Argentina.
Edgar E Matos BenavidesCentro de Referencia de Alergia, Asma e Inmunología - Instituto Nacional del Niño, Lima-Perú.
Andrea BauerDepartment of Dermatology, University Allergy Center, University Hospital Carl Gustav Carus, Technical University, Dresden, Germany.
Ana Maria Giménez-ArnauDepartment of Dermatology, Hospital del Mar, IMIM, Universitat Autònoma, Barcelona, Spain.
Emek KocatürkDepartment of Dermatology, Koç University School of Medicine, Istanbul, Turkey.
Carole GuilletDepartment of Dermatology, University Hospital Zurich, Switzerland.
Jose Ignacio LarcoAllergy Department, Clinica San Felipe, Lima, Peru.
Zuo-Tao ZhaoDepartment of Dermatology and Venereology, Peking University First Hospital, Beijing, China.
Michael MakrisAllergy Unit, 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, "Attikon" University Hospital, Greece.
Carla RitchieAllergy Division, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Paraskevi XepapadakiAllergy Department, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, Greece.
Luis Felipe EnsinaFederal University of São Paulo, São Paulo, Brazil.
Sofia CherrezDepartment of Dermatology, SRH Zentralklinikum Suhl, Germany.
Ivan Cherrez-OjedaUniversidad Espíritu Santo, Samborondón, Ecuador.
Charité - Universitätsmedizin Berlin · DEUniversidad de Especialidades Espíritu Santo · ECCleveland Clinic · USD.Y. Patil University · INMashhad University of Medical Sciences · IRMedical University of Silesia · PLNational and Kapodistrian University of Athens · GRCentro Peruano de Estudios Sociales · PECentro Universitário Academia · BRCity Clinical Hospital · RUErasmus MC · NLFaculdade de Medicina do ABC · BRHospital Italiano de Buenos Aires · ARHospital Universitário Clementino Fraga Filho · BRInstituto de Física del Sur · ARInstituto Nacional de Salud del Niño · PEKlinik für Psychosomatik · DEKoç University · TRPeking University · CNSechenov University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic urticaria (CU) is characterized by itchy recurrent wheals, angioedema, or both for 6 weeks or longer. CU can greatly impact patients' physical and emotional quality of life. Patients with chronic conditions are increasingly seeking information from information and communications technologies (ICTs) to manage their health. The objective of this study was to assess the frequency of usage and preference of ICTs from the perspective of patients with CU.

methodsIn this cross-sectional study, 1800 patients were recruited from primary healthcare centers, university hospitals or specialized clinics that form part of the UCARE (Urticaria Centers of Reference and Excellence) network throughout 16 countries. Patients were >12 years old and had physician-diagnosed chronic spontaneous urticaria (CSU) or chronic inducible urticaria (CIndU). Patients completed a 23-item questionnaire containing questions about ICT usage, including the type, frequency, preference, and quality, answers to which were recorded in a standardized database at each center. For analysis, ICTs were categorized into 3 groups as follows: one-to-one: SMS, WhatsApp, Skype, and email; one-to-many: YouTube, web browsers, and blogs or forums; many-to-many: Instagram, Twitter, Facebook, and LinkedIn.

resultsOverall, 99.6% of CU patients had access to ICT platforms and 96.7% had internet access. Daily, 85.4% patients used one-to-one ICT platforms most often, followed by one-to-many ICTs (75.5%) and many-to-many ICTs (59.2%). The daily ICT usage was highest for web browsers (72.7%) and WhatsApp (70.0%). The general usage of ICT platforms increased in patients with higher levels of education. One-to-many was the preferred ICT category for obtaining general health information (78.3%) and for CU-related information (75.4%). A web browser (77.6%) was by far the most commonly used ICT to obtain general health information, followed by YouTube (25.8%) and Facebook (16.3%). Similarly, for CU-specific information, 3 out of 4 patients (74.6%) used a web browser, 20.9% used YouTube, and 13.6% used Facebook. One in 5 (21.6%) patients did not use any form of ICT for obtaining information on CU. The quality of the information obtained from one-to-many ICTs was rated much more often as very interesting and of good quality for general health information (53.5%) and CU-related information (51.5%) as compared to the other categories.

conclusionsUsage of ICTs for health and CU-specific information is extremely high in all countries analyzed, with web browsers being the preferred ICT platform.

Indexed as

(3–5) ICTApps, applicationsCIndU, chronic inducible urticariaCSU, chronic spontaneous urticariaCU, chronic urticariaHCP, healthcare providerICT, information and communications technologiesInformation and communications technologySelf-managementSEM, self-management educationSMS, short messaging serviceUAE, United Arab EmiratesUCARE, Urticaria Centers of Reference and ExcellenceUrticaria

Identifiers

PMID33204387
PMCPMC7606865
OpenAlexW3095420587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.